Stuart A. Arbuckle
Board Member
Praxis Precision Medicines, Inc. (PRAX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stuart A. Arbuckle
Stuart A. Arbuckle is recorded as Board Member at Praxis Precision Medicines, Inc. (PRAX). Praxis Precision Medicines, Inc. reported in an 8-K filed January 8, 2026 that Stuart A. Arbuckle was appointed Class II director, effective January 8, 2026.
“On January 8, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Stuart A. Arbuckle to the Board as a Class II director, effective January 8, 2026, to serve until the 2028 annual meeting of stockholders or until his successor has been duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Praxis Precision Medicines, Inc.
Other people whose current roles at this company are on record from its filings.
- Marcio Souza CEO, Board Member
- Timothy E. Kelly CFO
- Timothy Kelly CFO
- Megan Sniecinski COO
- Alex Nemiroff General Counsel
- Gregory Norden Board Member
- Jeffrey B. Kindler Board Member
- Merit Cudkowicz, M.D. Board Member
- William Young Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.